Abbott Laboratories (ABT) Has Fallen -1.00%, Becoming A Losing Stock For Investors
Abbott Laboratories (NYSE:ABT) has a beta value of 0.71 and has seen 1.05 million shares traded in the recent trading session. The company, currently valued
Abbott Laboratories (NYSE:ABT) has a beta value of 0.71 and has seen 1.05 million shares traded in the recent trading session. The company, currently valued
Cenntro Inc (NASDAQ:CENN) has a beta value of 1.61 and has seen 0.46 million shares traded in the recent trading session. The company, currently valued
Skechers U S A, Inc (NYSE:SKX) has a beta value of 1.17 and has seen 1.08 million shares traded in the recent trading session. The
Novonix Limited ADR (NASDAQ:NVX) has a beta value of 2.59 and has seen 0.34 million shares traded in the recent trading session. The company, currently
JBS N.V (NYSE:JBS) has seen 1.08 million shares traded in the recent trading session. The company, currently valued at $6.53B, closed the recent trade at
Macy’s Inc (NYSE:M) has a beta value of 1.80 and has seen 1.02 million shares traded in the recent trading session. The company, currently valued
GE Aerospace (NYSE:GE) has a beta value of 1.45 and has seen 1.83 million shares traded in the recent trading session. The company, currently valued
Moolec Science SA (NASDAQ:MLEC) has a beta value of -0.38 and has seen 0.57 million shares traded in the recent trading session. The company, currently
Ryvyl Inc (NASDAQ:RVYL) has a beta value of 3.61 and has seen 5.8 million shares traded in the recent trading session. The company, currently valued
Vistra Corp (NYSE:VST) has a beta value of 1.31 and has seen 1.28 million shares traded in the recent trading session. The company, currently valued
© 2024, Powered by Smart TechOne